HOME > > Products > Glac Single Strain Probiotic > B. longum subsp. infantis BLI-02

B. longum subsp. infantis BLI-02

Share to

A patented functional strain derived from healthy human breast milk

BLI-02 is a probiotic strain isolated from healthy human breast milk. With a comprehensive patent portfolio and multiple peer-reviewed studies, BLI-02 demonstrates broad potential across several health-related areas, including supporting kidney function, maintaining glycemic balance, strengthening intestinal barrier integrity, modulating immune responses, providing antioxidant potential, and promoting GABA production. It has been successfully incorporated into multiple PRONULIFE® clinically validated formulations.
 

Core Areas of Application

  • Kidney Health Support: Scientific research indicates potential to promote healthy kidney function.

  • Glycemic Regulation: Demonstrates a functional role in helping maintain stable blood glucose metabolism.

  • Gut Health Promotion: Supports intestinal barrier integrity and helps maintain microbiota balance.

  • Immune Modulation: Shows potential in regulating inflammatory responses and supporting immune defense.

  • Antioxidant Potential: Patents and preclinical studies support its role in reducing oxidative stress and mitigating age-related decline.

  • Metabolite Production: Demonstrates the ability to promote GABA production, which may benefit neurological health.

 

 

Functional Applications in PRONULIFE® Formulations

Gut Health
PRONULIFE® IntProtect		Kidney Health
PRONULIFE® RenaProtect
 

 

Key Patents

Taiwan

  • I777107: Food and pharmaceutical compositions containing antioxidant lactic acid bacteria fermentation products

  • I759126: Use of lactic acid bacteria liquid cultures for anti-inflammatory support

  • I797881: Anti-aging compositions and applications for delaying senescence

  • I782550: Lactic acid bacteria compositions for reducing fat and enhancing exercise performance

  • I797600: Lactic acid bacteria compositions for enhancing brain function

  • I801057: Lactic acid bacteria compositions for improving gastrointestinal barrier function

China

  • CN115247138B: Lactic acid bacteria compositions for reducing fat and improving exercise performance

United States

  • US11779615B2: Lactic acid bacteria compositions for reducing fat and promoting exercise performance
     


📧 Contact us: glac@glac.com.tw
 

References
  • Probiotic Formula Ameliorates Renal Dysfunction Indicators, Glycemic Levels, and Blood Pressure in a Diabetic Nephropathy Mouse Model.
  • Probiotics and their Metabolites Reduce Oxidative Stress  in  Middle‑Aged Mice
  • The Function of Mixed Postbiotic PE0401 in Improving Intestinal Health via Elevating Anti-inflammation, Anti-oxidation, Epithelial Tight Junction Gene Expression and Promoting Beneficial Bacteria Growth
  • Effect of a Probiotic Combination in an Experimental Mouse Model and Clinical Patients With Chronic Kidney Disease: A Pilot Study
  • Synbiotics Alleviate the Gut Indole Load and Dysbiosis in Chronic Kidney Disease
  • Bacteriostatic abilities of viable and heat-killed lactic acid bacteria against group B Streptococcus
  • Assessment of bacteriostatic activities of viable and non-viable lactic acid bacteria against methicllin-resistant Staphylococcus aureus

 
Previous Back to list Next
Back
TOP